Top brokers name 3 ASX shares to buy next week 17 January 2021

Last week saw a number of broker notes hitting the wires once again. Three buy ratings that caught my eye are summarised below.

Here’s why brokers think investors ought to buy them next week:

According to a note out of Credit Suisse, its analysts have retained their outperform rating and $4.30 price target on this healthcare company’s shares. The broker believes that Healius is well-placed to benefit from increased demand for COVID testing. Combined with a reduction in costs and smart investments, it is expecting strong earnings growth in the near term. The Healius share price ended the week at $3.88.

Analysts at Morgan Stanley have initiated coverage on this investigative analytics and intelligence software provider’s…